Abstract

Compared to deep brain electrical stimulation, which has been applied to treating pathological brain diseases, little work has been done on the effect of deep brain light stimulation. A fiber-coupled laser stimulator at 840 nm wavelength and 130 Hz pulse repetition rate is developed in this work for deep brain light stimulation in a rat model. Concentration changes in glutamate and dopamine in the striatum are observed using a microdialysis probe when the subthalamic nucleus (STN) is stimulated at various optical power levels. Experimental results show that light stimulation causes the concentration of glutamate to decrease while that of dopamine is increased. This suggests that deep brain light stimulation of the STN is a promising therapeutic strategy for dopamine-related diseases such as Parkinson’s disease. The stimulator developed for this work is useful for deep brain light stimulation in biomedical research.

© 2014 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
Applications of digital holographic microscopy in therapeutic evaluation of Chinese herbal medicines

Chung-Hsin Wu, Xin-Ji Lai, Chau-Jern Cheng, Yu-Chen Yu, and Chun-Yen Chang
Appl. Opt. 53(27) G192-G197 (2014)

Hemodynamic responses in rat brain during transcranial direct current stimulation: a functional near-infrared spectroscopy study

Chang-Hee Han, Hyuna Song, Yong-Guk Kang, Beop-Min Kim, and Chang-Hwan Im
Biomed. Opt. Express 5(6) 1812-1821 (2014)

Spatial and temporal identification of cerebral infarctions based on multiphoton microscopic imaging

Shu Wang, Huiping Du, Bingbing Lin, Chenxi Liao, Xiaoqin Zhu, Xingfu Wang, Hong Chen, Shuangmu Zhuo, Liwei Jiang, Lianhuang Li, Haohua Tu, and Jianxin Chen
Biomed. Opt. Express 9(5) 2312-2325 (2018)

References

  • View by:
  • |
  • |
  • |

  1. F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).
  2. S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
    [Crossref] [PubMed]
  3. G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
    [Crossref] [PubMed]
  4. W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
    [Crossref] [PubMed]
  5. J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
    [Crossref] [PubMed]
  6. A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
    [Crossref] [PubMed]
  7. Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
    [Crossref] [PubMed]
  8. Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
    [Crossref] [PubMed]
  9. J. Tafur and P. J. Mills, “Low-intensity light therapy: exploring the role of redox mechanisms,” Photomed. Laser Surg. 26(4), 323–328 (2008).
    [Crossref] [PubMed]
  10. B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
    [PubMed]
  11. A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
    [Crossref] [PubMed]
  12. J. T. Ting and G. Feng, “Glutamatergic synaptic dysfunction and obsessive-compulsive disorder,” Curr Chem Genomics 2, 62–75 (2008).
    [Crossref] [PubMed]
  13. K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
    [Crossref] [PubMed]
  14. O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
    [Crossref] [PubMed]
  15. P. A. LeWitt, “Levodopa for the treatment of Parkinson’s Disease,” N. Engl. J. Med. 359(23), 2468–2476 (2008).
    [Crossref] [PubMed]
  16. C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
    [Crossref] [PubMed]
  17. B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
    [Crossref] [PubMed]
  18. B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
    [PubMed]
  19. P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
    [Crossref] [PubMed]
  20. J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
    [Crossref] [PubMed]
  21. Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
    [Crossref] [PubMed]
  22. L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
    [Crossref] [PubMed]
  23. B. K. Yamamoto and S. Davy, “Dopaminergic modulation of glutamate release in striatum as measured by microdialysis,” J. Neurochem. 58(5), 1736–1742 (1992).
    [Crossref] [PubMed]
  24. A. Abdo and M. Sahin, “NIR light penetration depth in the rat peripheral nerve and brain cortex,” in Proceedings of IEEE Conference on Engineering in Medicine and Biology Society (IEEE, 2007), pp. 1723–1725.
    [Crossref]
  25. A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
    [Crossref] [PubMed]

2013 (1)

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

2011 (1)

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

2010 (3)

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

2009 (3)

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

2008 (5)

J. Tafur and P. J. Mills, “Low-intensity light therapy: exploring the role of redox mechanisms,” Photomed. Laser Surg. 26(4), 323–328 (2008).
[Crossref] [PubMed]

J. T. Ting and G. Feng, “Glutamatergic synaptic dysfunction and obsessive-compulsive disorder,” Curr Chem Genomics 2, 62–75 (2008).
[Crossref] [PubMed]

P. A. LeWitt, “Levodopa for the treatment of Parkinson’s Disease,” N. Engl. J. Med. 359(23), 2468–2476 (2008).
[Crossref] [PubMed]

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

2007 (3)

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

2006 (1)

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

2005 (1)

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

2000 (2)

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
[Crossref] [PubMed]

1998 (1)

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

1997 (1)

K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
[Crossref] [PubMed]

1996 (1)

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

1992 (1)

B. K. Yamamoto and S. Davy, “Dopaminergic modulation of glutamate release in striatum as measured by microdialysis,” J. Neurochem. 58(5), 1736–1742 (1992).
[Crossref] [PubMed]

Abdo, A.

A. Abdo and M. Sahin, “NIR light penetration depth in the rat peripheral nerve and brain cortex,” in Proceedings of IEEE Conference on Engineering in Medicine and Biology Society (IEEE, 2007), pp. 1723–1725.
[Crossref]

Agid, Y.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Alexandrovich, A.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Alizadeh, H.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Andersson, B.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Andraus, R. A. C.

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

Andréewitch, S.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Aouizerate, B.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Arbus, C.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Ardouin, C.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Barbieri, C. H.

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

Barceló, A. C.

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Bardinet, E.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Bataille, B.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Baup, N.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Benabid, A. L.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Benabid, A.-L.

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Benazzouz, A.

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Bennet, K.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Blaha, C. D.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Borenstein, P.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Bougerol, T.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Brooks, D. J.

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

Burbaud, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Buy, X.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Caparo, C.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Carroll, J. D.

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

Chabardès, S.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Chang, S. Y.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Chang, T.-H.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Chaynes, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Chen, A. C.

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

Chen, H.-F.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Chéreau, I.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Chien, S.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Clarke, C. E.

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

Cornu, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Cosyns, P. R.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Czernecki, V.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Dahlof, B.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Damier, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Davy, S.

B. K. Yamamoto and S. Davy, “Dopaminergic modulation of glutamate release in striatum as measured by microdialysis,” J. Neurochem. 58(5), 1736–1742 (1992).
[Crossref] [PubMed]

De Deyn, P. P.

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

de Taboada, L.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Demeulemeester, H. G.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Derost, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Devaux, B.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Dietemann, J.-L.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Dittami, G. M.

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Dormont, D.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Drukarch, B.

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

du Montcel, S. T.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Dupont, P. J.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

El-Ani, D.

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Feng, G.

J. T. Ting and G. Feng, “Glutamatergic synaptic dysfunction and obsessive-compulsive disorder,” Curr Chem Genomics 2, 62–75 (2008).
[Crossref] [PubMed]

Fillipini, B.

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Fisher, M.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Fontaine, D.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Friehs, G. M.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Fu, Y.-J.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Gabriëls, L. A.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Gangi, A.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Gielen, F.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Goerss, S. J.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Goetz, C. G.

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

Goodman, W. K.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Greenberg, B. D.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Gybels, J. M.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Hamblin, M. R.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

Hashmi, J. T.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Hitchcock, R. W.

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Ho, J. H.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Höcht, C.

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Hoffmann, D.

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Houeto, J. L.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Huang, H.-D.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Huang, Y. Y.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

Ilic, S.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Jaafari, N.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Jahanshahi, M.

A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
[Crossref] [PubMed]

Jongenelen, C. A. M.

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

Kim, I. Y.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Kimble, C.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Korczyn, A. D.

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

Kornhuber, J.

K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
[Crossref] [PubMed]

Krack, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Krebs, M. O.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Kubu, C. S.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Lampl, Y.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Lang, A. E.

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

Lange, K. W.

K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
[Crossref] [PubMed]

Langeveld, C. H.

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

Lasher, R. A.

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Lee, K. H.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Lee, O. K.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Lew, R.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

LeWitt, P. A.

P. A. LeWitt, “Levodopa for the treatment of Parkinson’s Disease,” N. Engl. J. Med. 359(23), 2468–2476 (2008).
[Crossref] [PubMed]

Limousin, P.

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Lomastro, M. J.

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Maes, A. F.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Mallet, L.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Malloy, P. F.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Malone, D. A.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Mattei, V.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Mazzer, N.

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

Meyerson, B. A.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Millet, B.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Mills, P. J.

J. Tafur and P. J. Mills, “Low-intensity light therapy: exploring the role of redox mechanisms,” Photomed. Laser Surg. 26(4), 323–328 (2008).
[Crossref] [PubMed]

Naeser, M. A.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Nevo, Z.

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Nuttin, B. J.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Okun, M. S.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Ong, W.-K.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Oron, A.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Oron, U.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Osmani, B. Z.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Pazo, J. H.

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Pelissolo, A.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Perez, J.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Poewe, W.

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

Pollak, P.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

Polosan, M.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Quinn, N.

A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
[Crossref] [PubMed]

Rabbitt, R. D.

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Rajguru, S. M.

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Raoul, S.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Rascol, O.

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

Rasmussen, S. A.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Rezai, A. R.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Riederer, P.

K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
[Crossref] [PubMed]

Rochkind, S.

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Roy, C.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Sahin, M.

A. Abdo and M. Sahin, “NIR light penetration depth in the rat peripheral nerve and brain cortex,” in Proceedings of IEEE Conference on Engineering in Medicine and Biology Society (IEEE, 2007), pp. 1723–1725.
[Crossref]

Salloway, S. P.

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Sampaio, C.

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

Schepens, E.

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

Schrag, A.

A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
[Crossref] [PubMed]

Shahar, A.

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Sharma, S. K.

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Shohami, E.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Shon, Y. M.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Sousa, F. F. A.

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

Stoof, J. C.

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

Streeter, J.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Sunaert, S. G.

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Tafur, J.

J. Tafur and P. J. Mills, “Low-intensity light therapy: exploring the role of redox mechanisms,” Photomed. Laser Surg. 26(4), 323–328 (2008).
[Crossref] [PubMed]

Ting, J. T.

J. T. Ting and G. Feng, “Glutamatergic synaptic dysfunction and obsessive-compulsive disorder,” Curr Chem Genomics 2, 62–75 (2008).
[Crossref] [PubMed]

Trembovler, V.

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

Tsai, C.-T.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Van Gompel, J. J.

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Vérin, M.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Welin, L.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Welter, M. L.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Wong, L.

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Wong, Y.-S.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Yamamoto, B. K.

B. K. Yamamoto and S. Davy, “Dopaminergic modulation of glutamate release in striatum as measured by microdialysis,” J. Neurochem. 58(5), 1736–1742 (1992).
[Crossref] [PubMed]

Yelnik, J.

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Yen, D.-J.

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Zivin, J. A.

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Acta Ortop. Bras. (1)

F. F. A. Sousa, R. A. C. Andraus, C. H. Barbieri, and N. Mazzer, “Influence of laser radiation in nerve regeneration in different treatment sites,” Acta Ortop. Bras. 17(6), 331–335 (2009).

Am. Acad. Phys. Med. Rehabilitation (1)

J. T. Hashmi, Y. Y. Huang, B. Z. Osmani, S. K. Sharma, M. A. Naeser, and M. R. Hamblin, “Role of low-level laser therapy in neurorehabilitation,” Am. Acad. Phys. Med. Rehabilitation 2(12Suppl 2), S292–S305 (2010).
[Crossref] [PubMed]

Biomaterials (1)

W.-K. Ong, H.-F. Chen, C.-T. Tsai, Y.-J. Fu, Y.-S. Wong, D.-J. Yen, T.-H. Chang, H.-D. Huang, O. K. Lee, S. Chien, and J. H. Ho, “The activation of directional stem cell motility by green light-emitting diode irradiation,” Biomaterials 34(8), 1911–1920 (2013).
[Crossref] [PubMed]

Curr Chem Genomics (1)

J. T. Ting and G. Feng, “Glutamatergic synaptic dysfunction and obsessive-compulsive disorder,” Curr Chem Genomics 2, 62–75 (2008).
[Crossref] [PubMed]

Dose Response (1)

Y. Y. Huang, A. C. Chen, J. D. Carroll, and M. R. Hamblin, “Biphasic dose response in low level light therapy,” Dose Response 7(4), 358–383 (2009).
[Crossref] [PubMed]

J. Neurochem. (1)

B. K. Yamamoto and S. Davy, “Dopaminergic modulation of glutamate release in striatum as measured by microdialysis,” J. Neurochem. 58(5), 1736–1742 (1992).
[Crossref] [PubMed]

J. Neurol. Neurosurg. Psychiatry (1)

A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson’s disease?” J. Neurol. Neurosurg. Psychiatry 69(3), 308–312 (2000).
[Crossref] [PubMed]

J. Neurosci. (1)

B. Drukarch, C. A. M. Jongenelen, E. Schepens, C. H. Langeveld, and J. C. Stoof, “Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson’s disease,” J. Neurosci. 16(19), 6038–6045 (1996).
[PubMed]

J. Neurotrauma (1)

A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, and E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma 24(4), 651–656 (2007).
[Crossref] [PubMed]

J. Physiol. (1)

G. M. Dittami, S. M. Rajguru, R. A. Lasher, R. W. Hitchcock, and R. D. Rabbitt, “Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes,” J. Physiol. 589(6), 1295–1306 (2011).
[Crossref] [PubMed]

Lasers Surg. Med. (1)

S. Rochkind, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers Surg. Med. 41(4), 277–281 (2009).
[Crossref] [PubMed]

Mov. Disord. (1)

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004,” Mov. Disord. 20(5), 523–539 (2005).
[Crossref] [PubMed]

N. Engl. J. Med. (4)

O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group,” N. Engl. J. Med. 342(20), 1484–1491 (2000).
[Crossref] [PubMed]

P. A. LeWitt, “Levodopa for the treatment of Parkinson’s Disease,” N. Engl. J. Med. 359(23), 2468–2476 (2008).
[Crossref] [PubMed]

P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L. Benabid, “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease,” N. Engl. J. Med. 339(16), 1105–1111 (1998).
[Crossref] [PubMed]

L. Mallet, M. Polosan, N. Jaafari, N. Baup, M. L. Welter, D. Fontaine, S. T. du Montcel, J. Yelnik, I. Chéreau, C. Arbus, S. Raoul, B. Aouizerate, P. Damier, S. Chabardès, V. Czernecki, C. Ardouin, M. O. Krebs, E. Bardinet, P. Chaynes, P. Burbaud, P. Cornu, P. Derost, T. Bougerol, B. Bataille, V. Mattei, D. Dormont, B. Devaux, M. Vérin, J. L. Houeto, P. Pollak, A. L. Benabid, Y. Agid, P. Krack, B. Millet, and A. Pelissolo,“Subthalamic nucleus stimulation in severe obsessive-compulsive disorder,” N. Engl. J. Med. 359(20), 2121–2134 (2008).
[Crossref] [PubMed]

Neuropsychopharmacology (1)

B. D. Greenberg, D. A. Malone, G. M. Friehs, A. R. Rezai, C. S. Kubu, P. F. Malloy, S. P. Salloway, M. S. Okun, W. K. Goodman, and S. A. Rasmussen, “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31(11), 2384–2393 (2006).
[Crossref] [PubMed]

Neurosci. Biobehav. Rev. (1)

K. W. Lange, J. Kornhuber, and P. Riederer, “Dopamine/glutamate interactions in Parkinson’s disease,” Neurosci. Biobehav. Rev. 21(4), 393–400 (1997).
[Crossref] [PubMed]

Neurosci. Lett. (1)

Y. M. Shon, K. H. Lee, S. J. Goerss, I. Y. Kim, C. Kimble, J. J. Van Gompel, K. Bennet, C. D. Blaha, and S. Y. Chang, “High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery,” Neurosci. Lett. 475(3), 136–140 (2010).
[Crossref] [PubMed]

Neurosurgery (1)

B. J. Nuttin, L. A. Gabriëls, P. R. Cosyns, B. A. Meyerson, S. Andréewitch, S. G. Sunaert, A. F. Maes, P. J. Dupont, J. M. Gybels, F. Gielen, and H. G. Demeulemeester, “Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder,” Neurosurgery 62(6Suppl 3), 966–977 (2008).
[PubMed]

Photomed. Laser Surg. (1)

J. Tafur and P. J. Mills, “Low-intensity light therapy: exploring the role of redox mechanisms,” Photomed. Laser Surg. 26(4), 323–328 (2008).
[Crossref] [PubMed]

Radiology (1)

A. Gangi, H. Alizadeh, L. Wong, X. Buy, J.-L. Dietemann, and C. Roy, “Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients,” Radiology 242(1), 293–301 (2007).
[Crossref] [PubMed]

Stroke (1)

Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, S. Ilic, and U. Oron, “Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1),” Stroke 38(6), 1843–1849 (2007).
[Crossref] [PubMed]

Synapse (1)

J. H. Pazo, C. Höcht, A. C. Barceló, B. Fillipini, and M. J. Lomastro, “Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine,” Synapse 64(12), 905–915 (2010).
[Crossref] [PubMed]

Other (1)

A. Abdo and M. Sahin, “NIR light penetration depth in the rat peripheral nerve and brain cortex,” in Proceedings of IEEE Conference on Engineering in Medicine and Biology Society (IEEE, 2007), pp. 1723–1725.
[Crossref]

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (6)

Fig. 1
Fig. 1 (a) Schematic of deep brain laser-light stimulator. (b) Overall external appearance of the system.
Fig. 2
Fig. 2 Optical spectrum of the light stimulator showing 840 nm peak wavelength.
Fig. 3
Fig. 3 (a) Periodic structure of the optical chopper. (b) Temporal waveforms of the amplitude-modulated laser light at three modulation frequencies of 0 Hz (black), 50 Hz (red), and 130 Hz (blue). Note that a modulation frequency of 0 Hz yields the unmodulated CW output.
Fig. 4
Fig. 4 (a) Schematic top view of the rat brain. A rat is fixed on a stereotactic apparatus, which is used to accurately locate the stimulus fiber in the targeted STN and the microdialysis probe in the striatum. (b) Flow diagram of the experimental protocol.
Fig. 5
Fig. 5 Effects of light stimulation on glutamate in the striatum at three different optical power levels (2 mW, 5 mW, and 10 mW). The normalized glutamate concentration varies with the stimulating optical power. Sham animals were not optically stimulated. (N = 5 in each column.)
Fig. 6
Fig. 6 Effects of light stimulation on dopamine in the striatum at three different optical power levels (2 mW, 5 mW, and 10 mW). The normalized dopamine concentration varies with the stimulating optical power. Sham animals were not optically stimulated. (N = 5 in each column.)

Tables (1)

Tables Icon

Table 1 Deep Brain Light Stimulation

Metrics